Alembic Pharmaceuticals informs about press release

03 Jan 2019 Evaluate

Alembic Pharmaceuticals has informed about press release regarding the Company receives US Food & Drug Administration (USFDA) Approval Pramipexole Dihydrochloride Extended-Release Tablets, 0.375 mg, 0.75 mg, 1.5 mg, 2.25 mg, 3 mg, 3.75 mg, and 4.5 mg.

The above information is a part of company’s filings submitted to BSE.

Alembic Pharma Share Price

767.80 -7.50 (-0.97%)
19-Jan-2026 10:41 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1661.85
Dr. Reddys Lab 1170.20
Cipla 1376.35
Zydus Lifesciences 864.75
Lupin 2167.50
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×